0001437749-17-002067.txt : 20170209 0001437749-17-002067.hdr.sgml : 20170209 20170209210329 ACCESSION NUMBER: 0001437749-17-002067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170207 FILED AS OF DATE: 20170209 DATE AS OF CHANGE: 20170209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamel Lawrence G CENTRAL INDEX KEY: 0001511368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 17589293 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS INC. STREET 2: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 rdgdoc.xml FORM 4 2017 X0306 4 2017-02-07 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001511368 Hamel Lawrence G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Chief Development Officer Common Stock (Right to Buy) 3 2017-02-07 4 A 0 79500 0 A 2018-02-07 2028-02-06 Common Stock 79500 79500 D Issued pursuant to the 2011 Equity Incentive Plan. The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. 100% Acceleration upon Change of Control. /s/ Martha Adler, Attorney-in-Fact 2017-02-09